Risk and protective factors for dementia in cancer survivors vary by cancer type.

Authors

null

Bryan Neth

Mayo Clinic, Rochester, MN

Bryan Neth , Jonathan Graff-Radford , Eva Alden , Hugo Botha , Aditya Raghunathan , Derek R. Johnson , Daniel Honore Lachance , Ronald C. Petersen , Clifford R. Jack Jr., Prashanthi Vemuri , James Robert Cerhan , David S. Knopman

Organizations

Mayo Clinic, Rochester, MN

Research Funding

U.S. National Institutes of Health
U.S. National Institutes of Health

Background: Little is known about risk and protective factors for dementia in cancer survivors. With increasing longevity due to improved cancer therapy, it’s prudent to study factors contributing to cognitive impairment in this patient population. Methods: We performed multivariable cox regression analyses to assess established risk factors for all-cause dementia (age, education, APOE4-status, social and physical activity engagement) in breast and prostate cancer survivors. Patients 50+ years old with pathology-confirmed cancer diagnosis at Mayo Clinic were identified from a longitudinal, population-based cohort – Mayo Clinic Study of Aging. Analyses were controlled for age, APOE4-status, education, and cancer treatment. Results: We included a total of 209 patients with breast cancer (mean age 75.4 years, 24% APOE4-positive, median follow-up 6.8 years) and 352 with prostate cancer (mean age 77 years, 26% APOE4-positive, median follow-up 6.4 years). 31 patients with breast cancer (15%) and 66 patients with prostate cancer (20%) were diagnosed with dementia at last follow-up. Older age was associated with increased risk for dementia (5-year increase – breast: hazard ratio (HR) 1.9 [95%CI 1.3-2.7, p = 0.001]; prostate: HR 2.4 [95%CI 1.8-3.2, p < 0.0001]). APOE4-positivity was associated with increased dementia risk in breast (HR 3.6 [95%CI 1.6-7.8, p < 0.002]), but not prostate cancer (HR 1.2 [95%CI 0.7-2.0, p = 0.5]). More education was associated with lower dementia risk in prostate cancer (education year: HR 0.91 [95%CI 0.84-0.98, p < 0.02]; education years > 12: HR 0.26 [95%CI 0.1-0.6, p < 0.001]). Physical activity engagement in mid-life was associated with lower dementia risk (prostate: HR 0.56 [95%CI 0.4-0.8, p < 0.005]; breast: HR 0.48 [95%CI 0.3-0.9, p < 0.02]). Conclusions: In this longitudinal, population-based study we found that some risk and protective factors for dementia in cancer survivors vary by cancer type. While advanced age is an expected dementia risk factor, there were mixed results for APOE4-positivity (increased risk only in breast cancer) and education (only protective in prostate cancer). Our results support further study into factors influencing dementia risk by cancer type in hopes of identifying preventative strategies.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Abstract Details

Meeting

2023 ASCO Annual Meeting

Session Type

Publication Only

Session Title

Publication Only: Symptoms and Survivorship

Track

Symptom Science and Palliative Care

Sub Track

Late and Long-Term Adverse Effects

Citation

J Clin Oncol 41, 2023 (suppl 16; abstr e24089)

DOI

10.1200/JCO.2023.41.16_suppl.e24089

Abstract #

e24089

Abstract Disclosures

Similar Abstracts

Abstract

2024 ASCO Genitourinary Cancers Symposium

Endocrine and metabolic diseases among survivors of prostate cancer in a population-based cohort.

First Author: Siqi Hu

Abstract

2023 ASCO Quality Care Symposium

Demand for oncology visits among low-risk breast cancer survivors.

First Author: Emily H. Douglas

First Author: Hea Lim Choi

Abstract

2023 ASCO Annual Meeting

PAVING the path to wellness: Lifestyle medicine to improve outcomes in breast cancer survivors.

First Author: Hannah Lee